MedAdvisor has signed its second US agreement to provide medication education programs for a top 10 global pharmaceutical company. Digital medication management company MedAdvisor (ASX: MDR) has signed a second US agreement to provide a series of digital health education programs for a Top 10 global pharmaceutical company. The deal will be executed in conjunction with MedAdvisor’s strategic partner, US-based Adheris Health, which was engaged in March for an initial 12 month period to promote and jointly-sell MedAdvisor’s digital adherence programs to existing pharmaceutical clients. The health education programs comprise nine-month pilots designed to provide important education in a digital format to patients of four different medications over the next 12 months. The first four pilots have an estimated revenue of $825,000 for MedAdvisor and will be rolled out to a group of 4000 US pharmacies with a focus on program design, execution refinement and validation. Increasing scale MedAdvisor […]